Akeso
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Akeso
RECRUITINGPhase 3NCT06951503
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
This trial is a Phase III study. The purpose of this study is to evaluate the efficacy and safety of AK112 and chemotherapy versus bevacizumab and chemotherapy for the first-line...
Sponsor: AkesoEnrolling: 5602 locations
Colorectal Adenocarcinoma
RECRUITINGPhase 2NCT06560112
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
Sponsor: AkesoEnrolling: 1721 location
Recurrent Ovarian Cancer
RECRUITINGPhase 3NCT07023315
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ...
This study investigates treatment of cadonilimab or placebo combined with SOX chemotherapy (oxaliplatin + tegafur-gimeracil-oteracil potassium) given before surgery (neoadjuvant)...
Sponsor: AkesoEnrolling: 7606 locations
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma